SCHEMBL6628964

SCHEMBL6628964

CN1CCN(c2ccc(S(=O)(=O)NCCc3ccc(OC(N)=O)cc3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
LMNA P02545 4/20 0.55
MAPT P10636 3/20 0.55
POLB P06746 2/20 0.55
HTT P42858 2/20 0.55
HTR7 P34969 2/20 0.51
TP53 P04637 2/20 0.50
GFER P55789 1/20 0.47
HTR1A P08908 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5646848 0.83 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2LMNAMAPTPOLB
SCHEMBL28106920 0.79 GAA (0.56) ALDH1A1SMN1; SMN2LMNAMAPTPOLB
SCHEMBL23648904 0.72 L3MBTL1 (0.54) ALDH1A1SMN1; SMN2LMNAMAPTPOLB
SCHEMBL28571133 0.70 HRH3 (0.43) ALDH1A1TP53
SCHEMBL9128289 0.69 LSS (0.55) ALDH1A1SMN1; SMN2LMNAMAPTPOLB
SCHEMBL8840166 0.69 TBXA2R (0.64) ALDH1A1SMN1; SMN2POLB
SCHEMBL23928222 0.69 KMT2A (0.53) ALDH1A1HTR2AHTR2C
SCHEMBL9127531 0.69 LTA4H (0.59) ALDH1A1SMN1; SMN2POLBHTTHTR7
SCHEMBL8971065 0.69 TBXA2R (0.68) ALDH1A1SMN1; SMN2LMNAMAPTPOLB
SCHEMBL6629549 0.69 ADAMTS4 (0.57) ALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed